MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma
- PMID: 16818685
- DOI: 10.1158/1078-0432.CCR-05-2376
MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma
Abstract
Purpose: Mucoepidermoid carcinoma is the most common primary malignancy of the salivary gland. Mucoepidermoid carcinoma translocated gene 1-mastermind-like gene family (MECT1-MAML2) gene fusion was identified from a recurring t(11;19)(q21;p13) translocation, which is often the sole cytogenetic alteration in this disease. This fusion transcript has been frequently detected in mucoepidermoid carcinoma and shown to be involved in the transformation of epithelial cells. However, its clinicopathologic significance remains unclear.
Experimental design: Seventy-one cases of mucoepidermoid carcinoma and 51 cases of nonmucoepidermoid carcinoma salivary gland tumors (including 26 Warthin tumor cases) were retrospectively analyzed. RNA was extracted from archival materials: histologic paraffin specimens in all cases and cytologic specimens in 10 mucoepidermoid carcinoma cases. The MECT1-MAML2 fusion transcript was detected by a reverse transcription-PCR assay, which can be applied to both histologic and cytologic specimens. The presence of the fusion transcript was correlated with relevant clinicopathologic and survival data of the mucoepidermoid carcinoma patients.
Results: The MECT1-MAML2 fusion transcript was detected in 27 of the 71 (38%) mucoepidermoid carcinoma cases but not in any case of nonmucoepidermoid carcinoma tumors. The reverse transcription-PCR results showed no difference between histologic and cytologic specimens. Detection of the MECT1-MAML2 fusion transcript was associated with a less advanced clinical stage and a low-grade tumor histology. The presence of the transcript was associated with longer disease-free and overall survivals on univariate analysis and emerged as an independent prognostic factor for longer overall survival on multivariate analysis.
Conclusions: The MECT1-MAML2 fusion transcript may be specific to mucoepidermoid carcinoma and associated with a distinct mucoepidermoid carcinoma subset that exhibits favorable clinicopathologic features and an indolent clinical course.
Comment in
-
Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer.Clin Cancer Res. 2006 Jul 1;12(13):3878-81. doi: 10.1158/1078-0432.CCR-06-0791. Clin Cancer Res. 2006. PMID: 16818681 Review. No abstract available.
Similar articles
-
Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.J Oral Maxillofac Surg. 2009 Jul;67(7):1432-41. doi: 10.1016/j.joms.2009.03.021. J Oral Maxillofac Surg. 2009. PMID: 19531414
-
Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland.Oncol Rep. 2009 Aug;22(2):305-11. Oncol Rep. 2009. PMID: 19578770
-
t(11;19)(q21;p12~p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma.J Pediatr Surg. 2007 Jul;42(7):E23-9. doi: 10.1016/j.jpedsurg.2007.04.031. J Pediatr Surg. 2007. PMID: 17618868
-
Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature.Virchows Arch. 2017 Jun;470(6):619-626. doi: 10.1007/s00428-017-2104-4. Epub 2017 Mar 25. Virchows Arch. 2017. PMID: 28343305 Review.
-
t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.Oral Oncol. 2009 Jan;45(1):2-9. doi: 10.1016/j.oraloncology.2008.03.012. Epub 2008 May 16. Oral Oncol. 2009. PMID: 18486532 Review.
Cited by
-
Mucoepidermoid carcinoma of the pancreas: A case report and literature review.Medicine (Baltimore). 2024 Jan 26;103(4):e36993. doi: 10.1097/MD.0000000000036993. Medicine (Baltimore). 2024. PMID: 38277552 Free PMC article. Review.
-
Mucoepidermoid carcinoma in Warthin tumor of the parotid gland.Arch Med Sci. 2015 Jun 19;11(3):691-5. doi: 10.5114/aoms.2015.52379. Arch Med Sci. 2015. PMID: 26170867 Free PMC article. No abstract available.
-
Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens.Int J Mol Sci. 2023 Jan 15;24(2):1722. doi: 10.3390/ijms24021722. Int J Mol Sci. 2023. PMID: 36675234 Free PMC article.
-
Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.Virchows Arch. 2011 May;458(5):583-92. doi: 10.1007/s00428-011-1063-4. Epub 2011 Mar 11. Virchows Arch. 2011. PMID: 21394649
-
Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study.Sci Rep. 2017 Mar 6;7:43907. doi: 10.1038/srep43907. Sci Rep. 2017. PMID: 28262804 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical